This Dividend Stock has a 9% Yield

Here are three high yield dividend stocks Here are three high yield dividend stocks                                                                                                      You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please [unsubscribe]( here.  Dear Fellow Investor, Investing in dividend stocks can be a smart strategy for investors who are looking for a reliable source of income and long-term growth potential. Dividend stocks are especially attractive in a low-interest-rate environment, where traditional fixed-income investments offer lower yields. Additionally, dividend-paying companies tend to be more stable and profitable, making them a more conservative investment option. Here are three high yield dividend stocks - MPLX LP – SYM: MPLX Recent Price: $36.60 Yield: 9.34% Description: MPLX LP owns and operates midstream energy infrastructure and logistics assets primarily in the United States. It operates in two segments, Logistics and Storage, and Gathering and Processing. The company was incorporated in 2012 and is headquartered in Findlay, Ohio. MPLX LP operates as a subsidiary of Marathon Petroleum Corporation. === [CRITICAL Jan. 31st Warning]("Safe" investors who don't get out of cash now could lose everything over the next six months. For the first time that I've ever heard of…a bubble is about to burst on a schedule. Yes, we know the date when everything is going to change in the financial markets. As usual, the rich and elite are already way ahead of this. The good news is, there's a simple 3-step process to insulating yourself from this bubble. [To find out when the bubble is going to pop and how to get ahead of it, watch the FREE video here.]( === SL Green Realty Corp. – SYM: SLG Recent Price: $45.95 [Get Dividend Yield Here ]( Description: SL Green Realty Corp., Manhattan's largest office landlord, is a fully integrated real estate investment trust, or REIT, that is focused primarily on acquiring, managing and maximizing value of Manhattan commercial properties. As of September 30, 2023, SL Green held interests in 59 buildings totaling 32.5 million square feet. This included ownership interests in 28.8 million square feet of Manhattan buildings and 2.8 million square feet securing debt and preferred equity investments. === [7 High-Yield Dividend Stocks to Buy Now](Trading Tips has just released a new, free report. And it details seven companies that pay sky-high dividends. It's one of the best ways to collect easy, consistent payouts. And the companies we reveal in our report all pay out high yields. One of the companies, in fact, has even raised their dividend for nine years running. [Click here to claim your FREE copy of this report!]( (By clicking this link you agree to receive emails from us and our affiliates. You can opt out at any time.) === Pfizer Inc. – SYM: PFE Recent Price: $28.67 [Get Dividend Yield Here ]( Description: Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. === [The Secret Anchor Investment of The Rich & Powerful](There's ONE investment that's held by over 97.6% of the ultra wealthy that they would NEVER tell you about. And if they did, they will be modest on how heavy they are on this play in their portfolio. What they'll never tell you, is how they're leveraging a little-known tax-free loophole that allows you to invest in gold without putting up any of your own cash. This loophole allows you to opt out of the insanity in your traditional retirement account, for a specialized option that allows you to own precious metals tax free and penalty free. [Click here to claim your free copy of the Gold Investment Guide.]( === [Free trades! Delivered Right to Your Inbox]( Want more free daily trades in your inbox? [Sign up for Dylan Jovine's Daily Guru Trades]( "The Buck Stops Here" [youtube button]( [facebook button]( [instagram button]( Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2023 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( [Unsubscribe](